Curvebeam Ai Ltd (CVB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Curvebeam Ai Ltd (CVB) has a cash flow conversion efficiency ratio of -0.318x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-11.17 Million ≈ $-7.90 Million USD) by net assets (AU$35.11 Million ≈ $24.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Curvebeam Ai Ltd - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how Curvebeam Ai Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Curvebeam Ai Ltd for a breakdown of total debt and financial obligations.
Curvebeam Ai Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Curvebeam Ai Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Predictive Oncology Inc
NASDAQ:POAI
|
0.021x |
|
Hansol Inticube Co. Ltd
KQ:070590
|
-0.041x |
|
Century Extrusions Limited
NSE:CENTEXT
|
0.095x |
|
Carboclor
BA:CARC
|
0.039x |
|
KB SPAC 5
KQ:208350
|
-0.007x |
|
Seko S.A.
WAR:SEK
|
-0.002x |
|
Prostar Holdings Inc
V:MAPS
|
-0.535x |
|
OXE Marine AB
ST:OXE
|
-0.326x |
Annual Cash Flow Conversion Efficiency for Curvebeam Ai Ltd (2022–2025)
The table below shows the annual cash flow conversion efficiency of Curvebeam Ai Ltd from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see CVB market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$35.11 Million ≈ $24.84 Million |
AU$-11.17 Million ≈ $-7.90 Million |
-0.318x | +43.36% |
| 2024-06-30 | AU$38.92 Million ≈ $27.54 Million |
AU$-21.86 Million ≈ $-15.47 Million |
-0.562x | -224.65% |
| 2023-06-30 | AU$-48.10 Million ≈ $-34.03 Million |
AU$-21.67 Million ≈ $-15.34 Million |
0.451x | -- |
| 2022-06-30 | AU$0.00 ≈ $0.00 |
AU$-7.99 Million ≈ $-5.65 Million |
x | -- |
About Curvebeam Ai Ltd
CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and Australia. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot … Read more